05:14 AM EST, 03/08/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) said late Thursday it priced an upsized underwritten public offering of about 6.8 million shares at $62 apiece, targeting gross proceeds of $420 million.

The company said the offering will likely close on March 12.

Apogee, which is offering all of the shares in the sale, has granted underwriters a 30-day option to purchase up to about 1 million additional shares.

Shares of the company fell 2.4% in premarket activity Friday.

Price: 63.66, Change: -1.58, Percent Change: -2.42